img

Global Meningococcal Conjugate Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Meningococcal Conjugate Market Research Report 2024

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.
According to MRAResearch’s new survey, global Meningococcal Conjugate market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Meningococcal Conjugate market research.
Key companies engaged in the Meningococcal Conjugate industry include Sanofi Pasteur, Pfizer, Glaxo Smith Kline, Hualan Biological Engineering, JN International Medical Corporation, Baxter International, Merck, Serum Institute of India and Biomed, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Meningococcal Conjugate were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Meningococcal Conjugate market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Meningococcal Conjugate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi Pasteur
Pfizer
Glaxo Smith Kline
Hualan Biological Engineering
JN International Medical Corporation
Baxter International
Merck
Serum Institute of India
Biomed
Novartis
Segment by Type
Menactra
Menveo
NeisVac-C
Nimenrix
Others
Segment by End User
Children
Preteens or Teens
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Meningococcal Conjugate report covers below items
Chapter 1Product Basic Information (Definition, Type and End User)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product End User Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Conjugate Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Menactra
1.2.3 Menveo
1.2.4 NeisVac-C
1.2.5 Nimenrix
1.2.6 Others
1.3 Market by End User
1.3.1 Global Meningococcal Conjugate Market Growth by End User: 2018 VS 2022 VS 2033
1.3.2 Children
1.3.3 Preteens or Teens
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Meningococcal Conjugate Market Perspective (2018-2033)
2.2 Meningococcal Conjugate Growth Trends by Region
2.2.1 Global Meningococcal Conjugate Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Meningococcal Conjugate Historic Market Size by Region (2018-2023)
2.2.3 Meningococcal Conjugate Forecasted Market Size by Region (2024-2033)
2.3 Meningococcal Conjugate Market Dynamics
2.3.1 Meningococcal Conjugate Industry Trends
2.3.2 Meningococcal Conjugate Market Drivers
2.3.3 Meningococcal Conjugate Market Challenges
2.3.4 Meningococcal Conjugate Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Conjugate Players by Revenue
3.1.1 Global Top Meningococcal Conjugate Players by Revenue (2018-2023)
3.1.2 Global Meningococcal Conjugate Revenue Market Share by Players (2018-2023)
3.2 Global Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Conjugate Revenue
3.4 Global Meningococcal Conjugate Market Concentration Ratio
3.4.1 Global Meningococcal Conjugate Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Conjugate Revenue in 2022
3.5 Meningococcal Conjugate Key Players Head office and Area Served
3.6 Key Players Meningococcal Conjugate Product Solution and Service
3.7 Date of Enter into Meningococcal Conjugate Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Meningococcal Conjugate Breakdown Data by Type
4.1 Global Meningococcal Conjugate Historic Market Size by Type (2018-2023)
4.2 Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2033)
5 Meningococcal Conjugate Breakdown Data by End User
5.1 Global Meningococcal Conjugate Historic Market Size by End User (2018-2023)
5.2 Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2033)
6 North America
6.1 North America Meningococcal Conjugate Market Size (2018-2033)
6.2 North America Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Meningococcal Conjugate Market Size by Country (2018-2023)
6.4 North America Meningococcal Conjugate Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Meningococcal Conjugate Market Size (2018-2033)
7.2 Europe Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Meningococcal Conjugate Market Size by Country (2018-2023)
7.4 Europe Meningococcal Conjugate Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Conjugate Market Size (2018-2033)
8.2 Asia-Pacific Meningococcal Conjugate Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Meningococcal Conjugate Market Size by Region (2018-2023)
8.4 Asia-Pacific Meningococcal Conjugate Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Meningococcal Conjugate Market Size (2018-2033)
9.2 Latin America Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Meningococcal Conjugate Market Size by Country (2018-2023)
9.4 Latin America Meningococcal Conjugate Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Conjugate Market Size (2018-2033)
10.2 Middle East & Africa Meningococcal Conjugate Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Meningococcal Conjugate Market Size by Country (2018-2023)
10.4 Middle East & Africa Meningococcal Conjugate Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Detail
11.1.2 Sanofi Pasteur Business Overview
11.1.3 Sanofi Pasteur Meningococcal Conjugate Introduction
11.1.4 Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023)
11.1.5 Sanofi Pasteur Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Meningococcal Conjugate Introduction
11.2.4 Pfizer Revenue in Meningococcal Conjugate Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Glaxo Smith Kline
11.3.1 Glaxo Smith Kline Company Detail
11.3.2 Glaxo Smith Kline Business Overview
11.3.3 Glaxo Smith Kline Meningococcal Conjugate Introduction
11.3.4 Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023)
11.3.5 Glaxo Smith Kline Recent Development
11.4 Hualan Biological Engineering
11.4.1 Hualan Biological Engineering Company Detail
11.4.2 Hualan Biological Engineering Business Overview
11.4.3 Hualan Biological Engineering Meningococcal Conjugate Introduction
11.4.4 Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023)
11.4.5 Hualan Biological Engineering Recent Development
11.5 JN International Medical Corporation
11.5.1 JN International Medical Corporation Company Detail
11.5.2 JN International Medical Corporation Business Overview
11.5.3 JN International Medical Corporation Meningococcal Conjugate Introduction
11.5.4 JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023)
11.5.5 JN International Medical Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Detail
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Meningococcal Conjugate Introduction
11.6.4 Baxter International Revenue in Meningococcal Conjugate Business (2018-2023)
11.6.5 Baxter International Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Meningococcal Conjugate Introduction
11.7.4 Merck Revenue in Meningococcal Conjugate Business (2018-2023)
11.7.5 Merck Recent Development
11.8 Serum Institute of India
11.8.1 Serum Institute of India Company Detail
11.8.2 Serum Institute of India Business Overview
11.8.3 Serum Institute of India Meningococcal Conjugate Introduction
11.8.4 Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023)
11.8.5 Serum Institute of India Recent Development
11.9 Biomed
11.9.1 Biomed Company Detail
11.9.2 Biomed Business Overview
11.9.3 Biomed Meningococcal Conjugate Introduction
11.9.4 Biomed Revenue in Meningococcal Conjugate Business (2018-2023)
11.9.5 Biomed Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Meningococcal Conjugate Introduction
11.10.4 Novartis Revenue in Meningococcal Conjugate Business (2018-2023)
11.10.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Meningococcal Conjugate Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Menactra
Table 3. Key Players of Menveo
Table 4. Key Players of NeisVac-C
Table 5. Key Players of Nimenrix
Table 6. Key Players of Others
Table 7. Global Meningococcal Conjugate Market Size Growth by End User (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Meningococcal Conjugate Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Meningococcal Conjugate Market Share by Region (2018-2023)
Table 11. Global Meningococcal Conjugate Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Meningococcal Conjugate Market Share by Region (2024-2033)
Table 13. Meningococcal Conjugate Market Trends
Table 14. Meningococcal Conjugate Market Drivers
Table 15. Meningococcal Conjugate Market Challenges
Table 16. Meningococcal Conjugate Market Restraints
Table 17. Global Meningococcal Conjugate Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Meningococcal Conjugate Market Share by Players (2018-2023)
Table 19. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)
Table 20. Ranking of Global Top Meningococcal Conjugate Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Meningococcal Conjugate Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Conjugate Product Solution and Service
Table 24. Date of Enter into Meningococcal Conjugate Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Conjugate Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Meningococcal Conjugate Revenue Market Share by Type (2018-2023)
Table 28. Global Meningococcal Conjugate Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Meningococcal Conjugate Revenue Market Share by Type (2024-2033)
Table 30. Global Meningococcal Conjugate Market Size by End User (2018-2023) & (US$ Million)
Table 31. Global Meningococcal Conjugate Revenue Market Share by End User (2018-2023)
Table 32. Global Meningococcal Conjugate Forecasted Market Size by End User (2024-2033) & (US$ Million)
Table 33. Global Meningococcal Conjugate Revenue Market Share by End User (2024-2033)
Table 34. North America Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Meningococcal Conjugate Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Meningococcal Conjugate Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Meningococcal Conjugate Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Meningococcal Conjugate Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Meningococcal Conjugate Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Meningococcal Conjugate Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Meningococcal Conjugate Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Meningococcal Conjugate Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Meningococcal Conjugate Market Size by Country (2024-2033) & (US$ Million)
Table 49. Sanofi Pasteur Company Detail
Table 50. Sanofi Pasteur Business Overview
Table 51. Sanofi Pasteur Meningococcal Conjugate Product
Table 52. Sanofi Pasteur Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 53. Sanofi Pasteur Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Meningococcal Conjugate Product
Table 57. Pfizer Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Glaxo Smith Kline Company Detail
Table 60. Glaxo Smith Kline Business Overview
Table 61. Glaxo Smith Kline Meningococcal Conjugate Product
Table 62. Glaxo Smith Kline Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 63. Glaxo Smith Kline Recent Development
Table 64. Hualan Biological Engineering Company Detail
Table 65. Hualan Biological Engineering Business Overview
Table 66. Hualan Biological Engineering Meningococcal Conjugate Product
Table 67. Hualan Biological Engineering Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 68. Hualan Biological Engineering Recent Development
Table 69. JN International Medical Corporation Company Detail
Table 70. JN International Medical Corporation Business Overview
Table 71. JN International Medical Corporation Meningococcal Conjugate Product
Table 72. JN International Medical Corporation Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 73. JN International Medical Corporation Recent Development
Table 74. Baxter International Company Detail
Table 75. Baxter International Business Overview
Table 76. Baxter International Meningococcal Conjugate Product
Table 77. Baxter International Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 78. Baxter International Recent Development
Table 79. Merck Company Detail
Table 80. Merck Business Overview
Table 81. Merck Meningococcal Conjugate Product
Table 82. Merck Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Serum Institute of India Company Detail
Table 85. Serum Institute of India Business Overview
Table 86. Serum Institute of India Meningococcal Conjugate Product
Table 87. Serum Institute of India Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 88. Serum Institute of India Recent Development
Table 89. Biomed Company Detail
Table 90. Biomed Business Overview
Table 91. Biomed Meningococcal Conjugate Product
Table 92. Biomed Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 93. Biomed Recent Development
Table 94. Novartis Company Detail
Table 95. Novartis Business Overview
Table 96. Novartis Meningococcal Conjugate Product
Table 97. Novartis Revenue in Meningococcal Conjugate Business (2018-2023) & (US$ Million)
Table 98. Novartis Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Conjugate Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Meningococcal Conjugate Market Share by Type: 2022 VS 2033
Figure 3. Menactra Features
Figure 4. Menveo Features
Figure 5. NeisVac-C Features
Figure 6. Nimenrix Features
Figure 7. Others Features
Figure 8. Global Meningococcal Conjugate Market Size Comparison by End User (2023-2033) & (US$ Million)
Figure 9. Global Meningococcal Conjugate Market Share by End User: 2022 VS 2033
Figure 10. Children Case Studies
Figure 11. Preteens or Teens Case Studies
Figure 12. Adults Case Studies
Figure 13. Meningococcal Conjugate Report Years Considered
Figure 14. Global Meningococcal Conjugate Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Meningococcal Conjugate Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Meningococcal Conjugate Market Share by Region: 2022 VS 2033
Figure 17. Global Meningococcal Conjugate Market Share by Players in 2022
Figure 18. Global Top Meningococcal Conjugate Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Conjugate Revenue in 2022
Figure 20. North America Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Meningococcal Conjugate Market Share by Country (2018-2033)
Figure 22. United States Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Meningococcal Conjugate Market Share by Country (2018-2033)
Figure 26. Germany Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Meningococcal Conjugate Market Share by Region (2018-2033)
Figure 34. China Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Meningococcal Conjugate Market Share by Country (2018-2033)
Figure 42. Mexico Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Meningococcal Conjugate Market Share by Country (2018-2033)
Figure 46. Turkey Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Meningococcal Conjugate Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Sanofi Pasteur Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 50. Glaxo Smith Kline Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 51. Hualan Biological Engineering Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 52. JN International Medical Corporation Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 53. Baxter International Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 54. Merck Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 55. Serum Institute of India Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 56. Biomed Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 57. Novartis Revenue Growth Rate in Meningococcal Conjugate Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries